[HTML][HTML] Predominant role of mTOR signaling in skin diseases with therapeutic potential

F Karagianni, A Pavlidis, LS Malakou, C Piperi… - International Journal of …, 2022 - mdpi.com
The serine/threonine kinase mechanistic target of rapamycin (mTOR) plays a pivotal role in
the regulation of cell proliferation, survival, and motility in response to availability of energy …

Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease

MS Leo, RK Sivamani - Archives of Dermatological Research, 2014 - Springer
The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth,
proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two …

[HTML][HTML] The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling

J Wang, B Cui, Z Chen, X Ding - Frontiers in cell and developmental …, 2022 - frontiersin.org
The epidermis, the outmost layer of the skin, is a stratified squamous epithelium that protects
the body from the external world. The epidermis and its appendages need constantly renew …

[HTML][HTML] Recent updates on the involvement of PI3K/AKT/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders

L Mercurio, C Albanesi, S Madonna - Frontiers in medicine, 2021 - frontiersin.org
PhosphoInositide-3 Kinase (PI3K) represents a family of different classes of kinases which
control multiple biological processes in mammalian cells, such as cell growth, proliferation …

[HTML][HTML] The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy …

T Roy, ST Boateng, MB Uddin, S Banang-Mbeumi… - Cells, 2023 - mdpi.com
The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin
(mTOR) signaling pathway has been implicated in various immune-mediated inflammatory …

[HTML][HTML] Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic …

JC Chamcheu, T Roy, MB Uddin, S Banang-Mbeumi… - Cells, 2019 - mdpi.com
The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidyl-
inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation …

[HTML][HTML] mTOR signaling cascade in psoriatic disease: double kinase mTOR inhibitor a novel therapeutic target

SK Raychaudhuri… - Indian journal of …, 2014 - journals.lww.com
In this short communication we are providing insight about the regulatory role of the
phosphatidylinositol 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) kinase …

[HTML][HTML] mTOR signaling in metabolism and cancer

S Huang - Cells, 2020 - mdpi.com
The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a
central regulator for human physiological activity. Deregulated mTOR signaling is implicated …

[HTML][HTML] Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation

C Buerger, N Shirsath, V Lang, A Berard, S Diehl… - PLoS …, 2017 - journals.plos.org
Psoriasis is a frequent and often severe inflammatory skin disease, characterized by altered
epidermal homeostasis. Since we found previously that Akt/mTOR signaling is …

[HTML][HTML] Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target

C Buerger - Frontiers in immunology, 2018 - frontiersin.org
Although modern biologics targeting different inflammatory mediators show promising
therapeutic success, comprehensive knowledge about the molecular events in psoriatic …